European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias
European Atherosclerosis Journal · 2022
DOI: 10.56095/eaj.v1i2.14 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Atherosclerosis Journal, 2022. Verfasst von Asiiat Alieva und 2 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Current clinical guidelines on lipid metabolism disorders are represented by the integration of relevant multicenter observational studies and registries aimed to identify best strategies in cardiovascular risk stratification, diagnostics and treatment of dyslipidemias. The approaches outlined in the European, Russian and American clinical guidelines look relevant to each other despite a range slightly different postulates, as they all demonstrate a general tendency to the importance of accurate risk stratification of patients and timely action on low-density lipoprotein cholesterol (LDL-C) levels when using effective lipid-lowering therapy.
Zitieren
APA
Alieva, A., Usova, E., & Reutova, O. (2022). European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias. European Atherosclerosis Journal. https://doi.org/10.56095/eaj.v1i2.14
Vancouver
Alieva A, Usova E, Reutova O. European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias. European Atherosclerosis Journal. 2022. doi:10.56095/eaj.v1i2.14
BibTeX
@article{Alieva2022,
author = {Alieva, Asiiat and Usova, Elena and Reutova, Olga},
title = {European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias},
journal = {European Atherosclerosis Journal},
year = {2022},
doi = {10.56095/eaj.v1i2.14}
}
EUVIMED